Stengone Carmine N. sold CTNM
July 8, 2026 · Form 4 insider transaction
Stengone Carmine N. sold 2,500 shares of Contineum Therapeutics, Inc. at $16.00 per share, a transaction worth $40.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$16.00
Total value
$40.0K
InsiderStengone Carmine N.
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateJuly 8, 2026
Filing dateJuly 8, 2026
Shares owned after17,217
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.